Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice
Authors
Keywords
Matrix-M™ adjuvant, Influenza virus, MVA, Vaccine, Immunogenicity
Journal
IMMUNOLOGIC RESEARCH
Volume 66, Issue 2, Pages 224-233
Publisher
Springer Nature
Online
2018-03-29
DOI
10.1007/s12026-018-8991-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Enhancing protective immunity to malaria with a highly immunogenic virus-like particle vaccine
- (2017) Katharine A. Collins et al. Scientific Reports
- Matrix-M adjuvant enhances antibody, cellular and protective immune responses of a Zaire Ebola/Makona virus glycoprotein (GP) nanoparticle vaccine in mice
- (2016) Karin Lövgren Bengtsson et al. VACCINE
- Viral vector-based influenza vaccines
- (2016) Rory D. de Vries et al. Human Vaccines & Immunotherapeutics
- Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
- (2016) Sophie Detienne et al. Scientific Reports
- Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid–season results
- (2015) R G Pebody et al. Eurosurveillance
- Interim estimates of 2014/15 vaccine effectiveness against influenza A(H3N2) from Canada’s Sentinel Physician Surveillance Network, January 2015
- (2015) D M Skowronski et al. Eurosurveillance
- ISCOMATRIX™ adjuvant promotes epitope spreading and antibody affinity maturation of influenza A H7N9 virus like particle vaccine that correlate with virus neutralization in humans
- (2015) Ka Yan Chung et al. VACCINE
- Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial
- (2015) E. T. Overton et al. Open Forum Infectious Diseases
- Matrix-M Adjuvated Seasonal Virosomal Influenza Vaccine Induces Partial Protection in Mice and Ferrets against Avian H5 and H7 Challenge
- (2015) Freek Cox et al. PLoS One
- Broadly neutralizing hemagglutinin stalk–specific antibodies require FcγR interactions for protection against influenza virus in vivo
- (2014) David J DiLillo et al. NATURE MEDICINE
- Modified Vaccinia Virus Ankara (MVA) as Production Platform for Vaccines against Influenza and Other Viral Respiratory Diseases
- (2014) Arwen Altenburg et al. Viruses-Basel
- Matrix-M™ adjuvant: enhancing immune responses by ‘setting the stage’ for the antigen
- (2013) Karin Lövgren Bengtsson et al. Expert Review of Vaccines
- Adjuvanted influenza vaccines
- (2013) Orli Even-Or et al. Expert Review of Vaccines
- Monocyte-derived dendritic cells: targets as potent antigen-presenting cells for the design of vaccines against infectious diseases
- (2013) Chunfeng Qu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Substitutions Near the Receptor Binding Site Determine Major Antigenic Change During Influenza Virus Evolution
- (2013) B. F. Koel et al. SCIENCE
- Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice
- (2013) Sofia E. Magnusson et al. VACCINE
- Immunogenicity and efficacy of a chimpanzee adenovirus-vectored Rift Valley Fever vaccine in mice
- (2013) George M Warimwe et al. Virology Journal
- Genetic evolution of the neuraminidase of influenza A (H3N2) viruses from 1968 to 2009 and its correspondence to haemagglutinin evolution
- (2012) K. B. Westgeest et al. JOURNAL OF GENERAL VIROLOGY
- Lymph Node Macrophages
- (2012) Elizabeth E. Gray et al. Journal of Innate Immunity
- Matrix-M™ Adjuvant Induces Local Recruitment, Activation and Maturation of Central Immune Cells in Absence of Antigen
- (2012) Jenny M. Reimer et al. PLoS One
- Matrix-M adjuvanted virosomal H5N1 vaccine confers protection against lethal viral challenge in a murine model
- (2011) Gabriel Pedersen et al. Influenza and Other Respiratory Viruses
- Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
- (2011) Rebecca J. Cox et al. VACCINE
- Modified Vaccinia Virus Ankara Triggers Chemotaxis of Monocytes and Early Respiratory Immigration of Leukocytes by Induction of CCL2 Expression
- (2009) M. H. Lehmann et al. JOURNAL OF VIROLOGY
- Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations
- (2009) Karl G. Nicholson et al. VACCINE
- Intramuscular Matrix-M-adjuvanted virosomal H5N1 vaccine induces high frequencies of multifunctional Th1 CD4+ cells and strong antibody responses in mice
- (2009) Abdullah S. Madhun et al. VACCINE
- Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: Impact of distinct additional adjuvants
- (2008) Katarina Radošević et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now